Loading chat...
TN HB0070
Bill
Status
1/8/2025
Primary Sponsor
Esther Helton-Haynes
Click for details
AI Summary
-
TennCare health benefit plans renewed or issued on or after July 1, 2025 must provide coverage and reimbursement for biomarker testing to screen pregnant women for preeclampsia
-
Biomarker testing must be ordered by the pregnant woman's attending physician and conducted according to nationally recognized clinical practice guidelines
-
Biomarker testing includes FDA-approved methods such as single-analyte tests, multiplex panel tests, whole genome sequencing, and protein expression analysis
-
The Division of TennCare is authorized to promulgate rules and submit federal waiver applications to CMS to ensure federal Medicaid funding for the coverage
-
Rulemaking provisions take effect upon becoming law; all other provisions take effect July 1, 2025
Legislative Description
AN ACT to amend Tennessee Code Annotated, Title 56; Title 63; Title 68 and Title 71, relative to coverage of biomarker testing for preeclampsia.
TennCare
Last Action
Assigned to s/c Tenncare Subcommittee
1/28/2025